Comparative Pharmacology
Head-to-head clinical analysis: NORGESTIMATE AND ETHINYL ESTRADIOL versus PREMPRO PREMPHASE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NORGESTIMATE AND ETHINYL ESTRADIOL versus PREMPRO PREMPHASE.
NORGESTIMATE AND ETHINYL ESTRADIOL vs PREMPRO/PREMPHASE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination oral contraceptive: ethinyl estradiol suppresses gonadotropin release via estrogen receptor; norgestimate is a progestin that inhibits ovulation and thickens cervical mucus.
Prempro/Premphase contains conjugated estrogens (CE) and medroxyprogesterone acetate (MPA). Estrogens bind to estrogen receptors (ERα/ERβ), activating genomic and non-genomic signaling, promoting proliferation of estrogen-responsive tissues, and modulating lipid metabolism. MPA is a progestin that binds to progesterone receptors, antagonizing estrogen-induced endometrial hyperplasia and blunting estrogen effects on breast tissue. The combination suppresses gonadotropin secretion via negative feedback on the hypothalamic-pituitary axis.
One tablet (norgestimate 0.250 mg/ethinyl estradiol 0.035 mg) orally once daily for 21 consecutive days followed by 7 placebo tablets.
Conjugated estrogens 0.625 mg/medroxyprogesterone acetate 2.5 mg (Prempro) or 0.625 mg/5 mg (Premphase) orally once daily.
None Documented
None Documented
Norgestimate: ~21.3 hours (range 16-36 hours); active metabolite 17-deacetyl norgestimate: ~33.2 hours (range 22-45 hours). Ethinyl estradiol: ~17.1 hours (range 14-22 hours). Terminal half-life supports once-daily dosing; steady-state achieved within 10-14 days.
Conjugated estrogens: 10-24 hours (terminal, prolonged in hepatic impairment). Medroxyprogesterone acetate: 12-17 hours (terminal).
Urine (primarily as glucuronide and sulfate conjugates; ~50-60% of dose), feces (~30-40% of dose as metabolites), minimal unchanged drug in urine
Renal (90-95% as glucuronide and sulfate conjugates; <5% unchanged), biliary/fecal (5-10%).
Category D/X
Category C
Estrogen
Estrogen/Progestin Combination